Reports & Fillings

Investment Overview

Insights on growth, governance, and investors

  • Shareholders Information
  • Performance Highlights
  • Reports & Fillings
  • Corporate Governance
Stock Information

Track Our Stock Performance in Real Time

CURRENCY IRN
MARKET BSE
ISIN CODE INE767A01016
IRN TICKER CODE 524348
INDUSTRY PHARMASUTICALS
Contact Us

Investor Contact & Compliance Officers

Determining Materiality

Mr. Prakash M. Patil
Chairman, Managing Director & CEO

Mr. Harshit M. Savla
Jt. Managing Director

Mr. Adhish P. Patil
Chief Financial Officer & COO

Mahendra Industrial Estate, Plot No. 109-D, Road No. 29, Sion (East), Mumbai 400 022
Tel: 022-24048200 / 199
Fax: 022-2407 3462 / 0144
investorrelations@aartidrugs.com

Registrar & Share Transfer Agent

MUFG Intime India Pvt. Ltd. (Formerly Link Intime)

Unit: Aarti Drugs Ltd C-101, 247 Park, LBS Marg, Vikhroli (W), Mumbai – 400083
Tel: 022 – 4918 6000
Fax: 022 – 4918 6060
rnt.helpdesk@in.mpms.mufg.com
www.in.mpms.mufg.com

Grievances & Nodal Officer

Mr. Rushikesh Deole
Company Secretary & Compliance Officer

Ground Floor, Mahendra Industrial Estate, Plot No. 109-D, Road No. 29, Sion (East), Mumbai 400 022
Tel: 022-24048200 / 199
investorrelations@aartidrugs.com

Investor Presentation Download
Investor Presentation, March 2025
Investor Presentation, December 2024
Investor Presentation, Sept 2024
Investor Presentation_AGM_20.09.2024
Investor Presentation, June 2024
Investor Presentation, March 2024
Investor Presentation, December 2023
Investor Presentation, Sept 2023
Investor Presentation_AGM_26.09.2023
Investor Presentation, June 2023
Investor Presentation, Mar 2023
Investor Presentation, Dec 2022
Investor Presentation, Sept 2022
Investor Presentation_AGM_04.08.2022
Investor Presentation, June 2022
Investor Presentation, March 2022
Investor Presentation, December 2021
Investor Presentation, September 2021
Investor Presentation, June 2021
Investor Presentation, March 2021
Investor Presentation, December 2020
Investor Presentation, September 2020
Investor Presentation, June 2020
Investor Presentation, March 2020
Investor Presentation, March 2019
Investor Presentation, September 2018